{"id":"W2101199621","doi":"10.1002/hep.26386","title":"Faldaprevir combined with peginterferon alfa-2a and ribavirin in chronic hepatitis C virus genotype-1 patients with prior nonresponse: SILEN-C2 trial","year":2013,"lang":"en","type":"article","venue":"Hepatology","topic":"Hepatitis C virus research","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"ca_institutions":"Boehringer Ingelheim (Canada); University of Alberta","funders":"Gilead Sciences; Pfizer; Bristol-Myers Squibb","keywords":"Ribavirin; Medicine; Gastroenterology; Internal medicine; Adverse effect; Hepatitis C virus; Viral load; Boceprevir; Immunology; Human immunodeficiency virus (HIV); Virus","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002959613,0.0003930515,0.0009402683,0.0004065063,0.0001013686,0.00004995778,0.0002065464,0.0002844582,0.001114337],"category_scores_gemma":[0.0002783804,0.0002963185,0.00005003167,0.0004013444,0.0004544196,0.0002372637,0.0001589262,0.0006425506,0.0004362901],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005441337,"about_ca_system_score_gemma":0.0008132726,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.01419501,"about_ca_topic_score_gemma":0.03785674,"domain_scores_codex":[0.9968241,0.0005333537,0.000554715,0.0007165369,0.0005075234,0.0008638028],"domain_scores_gemma":[0.9982321,0.000320801,0.0001502431,0.0006350478,0.0003075181,0.000354325],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04792912,0.000478502,0.9318821,0.0001379524,0.0001103863,0.0002811862,0.0002306058,0.000001179778,0.0004934746,0.00005383473,0.0008785086,0.01752309],"study_design_scores_gemma":[0.09204971,0.02132417,0.8750954,0.0002544642,0.00008457941,0.00006569862,0.00001597553,0.001825102,0.0007123304,0.00003133349,0.008068622,0.0004726506],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9940766,0.0003798889,0.00005833333,0.0008857152,0.0001149722,0.003718789,0.00003193465,0.00007800099,0.000655789],"genre_scores_gemma":[0.9971766,0.0005684534,0.0004074327,0.0003829093,0.00008392335,0.000649893,0.00009430769,0.00008656944,0.0005498377],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05678679,"threshold_uncertainty_score":0.9999489,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01512678579575553,"score_gpt":0.2764275641954025,"score_spread":0.261300778399647,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}